Dr Reddy’s Laboratories has launched its over-the-counter (OTC) fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg / 120 mg - a bioequivalent generic version of Allegra-D 12 Hour Allergy & Congestion - in the US market on November 18, 2014. Dr Reddy’s ANDA is approved by the US Food & Drug Administration (USFDA).
The Allegra-D 12 Hour brand has US sales of approximately $ 49.8 million for the latest 52 weeks ending October 6, 2014 for total US multi outlet, according to IRI.
Dr Reddy’s fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg / 120 mg is available in a 20 count blister.
The Allegra-D 12 Hour brand has US sales of approximately $ 49.8 million for the latest 52 weeks ending October 6, 2014 for total US multi outlet, according to IRI.
Dr Reddy’s fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg / 120 mg is available in a 20 count blister.